ODTX (Odyssey Therapeutics) FCF Margin %: 0.00% (As of Mar. 2026)


ODTX Odyssey Therapeutics Inc ODTX
9 GF Score
Price $19.25
! 2 Warning Signs
View Full Analysis

What is Odyssey Therapeutics FCF Margin %?

Odyssey Therapeutics ODTX +2.01% 9 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ODTX with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Odyssey Therapeutics ranks worse than 81.82% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Odyssey Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-41.18 Mil. Odyssey Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Odyssey Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Odyssey Therapeutics's current FCF Yield % is -4.45%.

The historical rank and industry rank for Odyssey Therapeutics's FCF Margin % or its related term are showing as below:

ODTX' s FCF Margin % Range Over the Past 10 Years
Min: -11358.15   Med: -4391.8   Max: -1383.84
Current: -1383.84

During the past 4 years, the highest FCF Margin % of Odyssey Therapeutics was -1383.84%. The lowest was -11358.15%. And the median was -4391.80%.

ODTX's FCF Margin % is ranked worse than
81.82% of 957 companies
in the Biotechnology industry
Industry Median: -84.65 vs ODTX: -1383.84

Odyssey Therapeutics FCF Margin % Related Terms

Odyssey Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Odyssey Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Therapeutics FCF Margin % Chart

Odyssey Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 -11,358.15 -2,643.90 -4,391.80

Odyssey Therapeutics Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 -2,061.94 0.00 0.00

ODTX vs VOR, PHAT, GERN: FCF Margin % Comparison

For the Biotechnology subindustry, Odyssey Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Odyssey Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Odyssey Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Odyssey Therapeutics's FCF Margin % falls into.


ODTX
9GF Score
Odyssey Therapeutics Inc ODTX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Odyssey Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Odyssey Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-130.7/2.976
=-4,391.80 %

Odyssey Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-41.183/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Odyssey Therapeutics (ODTX) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Odyssey Therapeutics and its competitors. According to the industry distribution chart, Odyssey Therapeutics ranks #783 out of 957 companies in the Biotechnology industry, placing it in the top 81.8%.
Is Odyssey Therapeutics' FCF Margin % too high?
Odyssey Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Odyssey Therapeutics ranks #783 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Odyssey Therapeutics has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Odyssey Therapeutics' FCF Margin % compare to VOR and PHAT?
According to the Biotechnology industry distribution chart, Odyssey Therapeutics ranks #783 out of 957 companies for FCF Margin %. This places Odyssey Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Odyssey Therapeutics and its competitors. Odyssey Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Therapeutics stock overvalued right now?
Odyssey Therapeutics (ODTX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Odyssey Therapeutics' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Odyssey Therapeutics (ODTX), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Therapeutics Business Description

Address 51 Sleeper Street, Boston, MA, USA, 02210
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
9GF Score

Get the complete analysis for ODTX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price